Skip to content

THE NASAL SPRAY
THAT KILLS VIRUSES

Firebrick Pharma is an Australian pharmaceutical innovator with a breakthrough product

ABOUT FIREBRICK PHARMA

Firebrick Pharma has developed a broad-spectrum anti-viral nasal spray that could be an effective treatment for preventative respiratory viral infections, such as the common cold.

Firebrick Pharma Pty Ltd is an Australian private company, founded in 2012 by two experienced pharmaceutical and biotech executives.

Drawing on their expertise in drug development and respiratory viral diseases, their vision was to create a treatment for the common cold using an entirely innovative approach.

Featured On

Latest News